Tumor and Endothelial Cell Hybrids Participate in Glioblastoma Vasculature

Background. Recently antiangiogenic therapy with bevacizumab has shown a high but transient efficacy in glioblastoma (GBM). Indeed, GBM is one of the most angiogenic human tumors and endothelial proliferation is a hallmark of the disease. We therefore hypothesized that tumor cells may participate in...

Descripción completa

Detalles Bibliográficos
Autores principales: El Hallani, Soufiane, Colin, Carole, El Houfi, Younas, Idbaih, Ahmed, Boisselier, Blandine, Marie, Yannick, Ravassard, Philippe, Labussière, Marianne, Mokhtari, Karima, Thomas, Jean-Léon, Delattre, Jean-Yves, Eichmann, Anne, Sanson, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017715/
https://www.ncbi.nlm.nih.gov/pubmed/24868550
http://dx.doi.org/10.1155/2014/827327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017715/
https://www.ncbi.nlm.nih.gov/pubmed/24868550
http://dx.doi.org/10.1155/2014/827327

Ejemplares similares